GPs asked to watch out for ketoacidosis with patients on SGLT2 inhibitors
There's a high risk in those undergoing surgery, says diabetes society
14th August 2019
By Kemal Atlay
Patients on SGLT2 inhibitors need to pause treatment if they are unwell or about to undergo major surgery, diabetologists say, amid increasing reports of ketoacidosis associated with the drugs.
Associate Professor Neale Cohen.
The Australian Diabetes Society has updated an alert, warning doctors about the “small but definite risk” of severe diabetic ketoacidosis (DKA) that has landed surgical patients in ICU.